Yue Su

Dr. Yue Su


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Stem Cell Reviews and Reports
Verified
Journal Article
Open access
PDF file
HGHaiyan Guo
Haiyan Guo
YSYue Su
Yue Su
FDFang Deng
Fang Deng
Mesenchymal stromal cells (MSCs) as a kind of pluripotent adult stem cell have shown great therapeutic potential in relation to many diseases in anti-inflammation and regeneration. The results of preclinical experiments and clinical trials have demonstrated that MSC-derived secretome possesses immunoregulatory and reparative abilities and that this secretome is capable of modulating innate and adaptive immunity and reprograming the metabolism of recipient cells via paracrine mechanisms. It has been recognized that MSC-derived secretome, including soluble proteins (cytokines, chemokines, growth factors, proteases), extracellular vesicles (EVs) and organelles, plays a key role in tissue repair and regeneration in bronchopulmonary dysplasia, acute respiratory distress syndrome (ARDS), bronchial asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension, and silicosis. This review summarizes the known functions of MSC-EV modulation in lung diseases, coupled with the future challenges of MSC-EVs as a new pharmaceutical agent. The identification of underlying mechanisms for MSC-EV might provide a new direction for MSC-centered treatment in lung diseases.Graphical abstract

12 October 2024 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
YSYue Su
Yue Su
YZYouqian Zhang
Youqian Zhang
DZDi Zhang
Di Zhang
JXJin-Fu Xu
Jin-Fu Xu
Background: Sarcopenia (SP) is an aging-related loss of muscle mass and function, affecting the respiratory system. However, the causality of the association between sarcopenia on lung diseases remains elusive. Methods: The bidirectional univariate Mendelian randomization (UVMR), multivariate MR (MVMR) analysis, and mediation MR were utilized to systematically investigate the genetic causal relationship of SP and 11 respiratory diseases. Independent genomic variants related to sarcopenia or respiratory diseases were identified as instrumental variables (IVs), and the summary level data of genome-wide associated studies (GWAS) were obtained from the UK biobank and FinnGen. MVMR analysis was conducted to explore the mediation effects of body mass index (BMI), Alcohol Use Disorders Identification Test (AUDIT), smoking, education attainment (EA), physical activity, and Type 2 Diabetes Mellitus (T2DM). Results: Forward UVMR analysis based on the primary method revealed that pneumoconiosis was associated with a higher risk of appendicular lean mass (ALM) (OR = 1.01, p = 0.03), and BMI (10.65%), smoking (10.65%), and physical activity (17.70%) had a mediating role in the effect of pneumoconiosis on ALM. In reverse MR analysis, we found that genetically predicted ALM was significantly associated with an increased risk of pulmonary embolism (PE) (OR = 1.24, p = 7.21E-05). Chronic obstructive pulmonary disease (COPD) (OR = 0.98, p = 0.002) and sarcoidosis (OR = 1.01, p = 0.004) were identified to increase the loss of left-hand grip strength (HGS). Conversely, the increase in left- HGS presented a protective effect on chronic bronchitis (CB) (OR = 0.35, p = 0.03), (OR = 0.80, p = 0.02), and asthma (OR = 0.78, p = 0.04). Similarly, the loss of the right-HGS elevated the risk of low respiratory tract infection (LRTI) (OR = 0.97, p = 0.02) and bronchiectasis (OR = 1.01, p = 0.03), which is also an independent protective factor for LRTI and asthma. In the aspects of low HGS, the risk of LRTI was increased after MVMR analysis, and the risk of sarcoidosis and pneumoconiosis was elevated in the reverse analysis. Lastly, asthma was found to be related to the loss of the usual walking pace, and the reverse MR analysis suggested a causal relationship between the usual walking pace and LRTI (OR = 0.32, p = 2.79 × 10−5), asthma (OR = 0.24, p = 2.09 × 10−6), COPD (OR = 0.22, p = 6.64 × 10−4), and PE(OR = 0.35, p = 0.03). Conclusions: This data-driven MR analysis revealed SP was bidirectional causally associated with lung diseases, providing genetic evidence for further mechanistic and clinical studies to understand the crosstalk between SP and lung diseases.

24 November 2024 in Biological Research
Verified
Journal Article
Open access
PDF file
QJQiongqiong Ji
Qiongqiong Ji
YLYuanhao Lv
Yuanhao Lv
BHBei Hu
Bei Hu
YSYue Su
Yue Su
ISImran Ibrahim Shaikh
Imran Ibrahim Shaikh
XZXu Zhu
Xu Zhu
Induced neural stem cells (iNSCs), which have similar properties to neural stem cells and are able to self-proliferate and differentiate into neural cell lineages, are expected to be potential cells for the treatment of neurodegeneration disease. However, cell therapy based on iNSCs transplantation is limited by the inability to acquire sufficient quantities of iNSCs. Previous studies have found that mouse and human fibroblasts can be directly reprogrammed into iNSCs with a single factor, Sox2. Here, we induced mouse embryonic fibroblasts (MEFs) into iNSCs by combining valproic acid (VPA) with the induction factor Sox2, and the results showed that VPA significantly improved the conversion efficiency of fibroblasts to iNSCs. The iNSCs exhibited typical neurosphere-like structures that can express NSCs markers, such as Sox2, Nestin, Sox1, and Zbtb16, and could differentiate into neurons, astrocytes, and oligodendrocytes in vitro. Subsequently, the iNSCs were stereotactically transplanted into the hippocampus of APP/PS1 double transgenic mice (AD mice). Post-transplantation, the iNSCs showed long-term survival, migrated over long distances, and differentiated into multiple types of functional neurons and glial cells in vivo. Importantly, the cognitive abilities of APP/PS1 mice transplanted with iNSCs exhibited significant functional recovery. These findings suggest that VPA enhances the conversion efficiency of fibroblasts into iNSCs when used in combination with Sox2, and iNSCs hold promise as a potential donor material for transplantation therapy in Alzheimer’s disease.

5 September 2021 in European Respiratory Journal
Verified
Conference Paper
Closed access
YSYue Su
Yue Su
DSDavid Simpson
David Simpson
COCecilia O’kAne
Cecilia O’kAne
DBDerek Brazil
Derek Brazil
AKAnna Krasnodembskaya
Anna Krasnodembskaya
Background: Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) are investigated as a novel therapy for ARDS, a better understanding of their mechanism of action is needed. Macrophages are important mediators of ARDS inflammatory response. Suppressor of Cytokine Signalling (SOCS) proteins are key regulators of macrophage phenotype switch. Aim: To investigate the role of SOCS1 protein in the EV modulation of macrophages. Hypothesis: EVs modulate SOCS1 via transfer of miRNA. Methods: human monocyte-derived macrophages (MDMs) were stimulated with LPS or ARDS plasma and treated with EVs. Protein expression was tested by Western blot. EV miR content was determined by MiRseq. Specific siRNAs, inhibitors, miR mimic were used to silence protein expression and to modulate expression of miR181a. In vivo: LPS-injured C57BL/6 mice were given EVs with and without miR181a. Results: EVs significantly reduced secretion of TNF-a and IL-8 by MDMs in the presence of LPS or ARDS plasma, effect was critically dependent on SOCS1. Transfer of miR181 in EVs downregulated PTEN and subsequently activated pSTAT5 leading to upregulation of SOCS1. In vivo EVs alleviated lung injury and upregulated pSTAT5 and SOCS1 in alveolar macrophages in a miR181-dependent manner. Conclusion: miRNA181a-PTEN-pSTAT5-SOCS1 is a novel pathway regulating inflammatory response in ARDS. .

5 September 2026
Verified
Conference Paper
Closed access
YSYue Su
Yue Su
ZCZhihao Chen
Zhihao Chen
HSHongming Shan
Hongming Shan
JXJinfu Xu
Jinfu Xu
Background: Pseudomonas aeruginosa (PA) and nontuberculous mycobacteria (NTM) infections are associated with worse clinical outcomes in bronchiectasis, including more severe airway inflammation and frequent exacerbations. Early identification of these pathogens remains challenging. Aims: To investigate whether artificial intelligence (AI)–based analysis of chest CT imaging can improve the identification of PA infection and NTM disease in patients with bronchiectasis. Methods: Patients with bronchiectasis were identified from the Chinese Bronchiectasis Registry. Those with available chest CT scans and confirmed etiological pathogens were included(N=2457). A deep learning framework based on a multi-view, multi-scale convolutional neural network was developed. Tri-planar CT projections (axial, coronal, sagittal) were used as model inputs, with a multi-scale 2D ShuffleNet backbone for feature extraction. A multimodal fusion module integrated imaging features with clinical phenotypic data. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). Results: The vision-only model achieved an AUC of 0.856 for PA infection and 0.810 for NTM disease. Incorporation of clinical data into the multimodal fusion model further improved performance, with AUCs of 0.864 for PA and 0.851 for NTM. Gradient-weighted class activation mapping demonstrated spatial correspondence between model-identified regions and bronchiectatic lesions. Conclusions: AI-based analysis of chest CT imaging, particularly when combined with clinical data, shows good performance in identifying PA infection and NTM disease in bronchiectasis and may support earlier etiological recognition in clinical practice.